Find Scholarly Works

Search in all content

Filters for Scholarly Works

Search concepts
Selected Filters

Publication Year

  • 2019
  • 2018
  • 2016
  • 2014
  • 2011

Author

  • Keith Lindor

Advances in primary sclerosing cholangitis

Horsley-Silva, J. L., Carey, E. J. & Lindor, K., 2016, In : The Lancet Gastroenterology and Hepatology. 1, 1, p. 68-77 10 p.

Research output: Contribution to journalReview article

11 Scopus citations
5 Scopus citations

Alkaline phosphatase normalization is a biomarker of improved survival in primary sclerosing cholangitis

Hilscher, M., Enders, F. B., Carey, E. J., Lindor, K. & Tabibian, J. H., Mar 1 2016, In : Annals of Hepatology. 15, 2, p. 246-253 8 p.

Research output: Contribution to journalArticle

25 Scopus citations

Alkaline phosphatase normalization is associated with better prognosis in primary sclerosing cholangitis

Stanich, P. P., Björnsson, E., Gossard, A. A., Enders, F., Jorgensen, R. & Lindor, K. D., Apr 2011, In : Digestive and Liver Disease. 43, 4, p. 309-313 5 p.

Research output: Contribution to journalArticle

104 Scopus citations

A major step towards effective treatment evaluation in primary biliary cirrhosis

Beuers, U. & Lindor, K. D., Dec 2011, In : Journal of Hepatology. 55, 6, p. 1178-1180 3 p.

Research output: Contribution to journalEditorial

12 Scopus citations

A model for integration of formal knowledge and clinical experience: The Advanced Doctoring course at Mayo Medical School

Dyrbye, L. N., Starr, S. R., Thompson, G. B. & Lindor, K. D., Sep 2011, In : Academic Medicine. 86, 9, p. 1130-1136 7 p.

Research output: Contribution to journalArticle

9 Scopus citations

An overview of current and future therapeutic strategies for the treatment of primary sclerosing cholangitis

Ali, A. H., Carey, E. J. & Lindor, K., Jun 2014, In : Expert Opinion on Orphan Drugs. 2, 6, p. 545-556 12 p.

Research output: Contribution to journalReview article

2 Scopus citations

Antibiotics for the treatment of primary sclerosing cholangitis

Elfaki, D. A. H. & Lindor, K. D., May 1 2011, In : American Journal of Therapeutics. 18, 3, p. 261-265 5 p.

Research output: Contribution to journalArticle

17 Scopus citations

Antimitochondrial Antibody–Negative Primary Biliary Cholangitis: Is It Really the Same Disease?

Chascsa, D. M. & Lindor, K., Jan 1 2018, (Accepted/In press) In : Clinics in Liver Disease.

Research output: Contribution to journalArticle

3 Scopus citations

A Placebo-controlled trial of obeticholic acid in primary biliary cholangitis

Nevens, F., Andreone, P., Mazzella, G., Strasser, S. I., Bowlus, C., Invernizzi, P., Drenth, J. P. H., Pockros, P. J., Regula, J., Beuers, U., Trauner, M., Jones, D. E., Floreani, A., Hohenester, S., Luketic, V., Shiffman, M., Van Erpecum, K. J., Vargas, V., Vincent, C., Hirschfield, G. M. & 12 others, Shah, H., Hansen, B., Lindor, K., Marschall, H. U., Kowdley, K. V., Hooshmand-Rad, R., Marmon, T., Sheeron, S., Pencek, R., MacConell, L., Pruzanski, M. & Shapiro, D., Aug 18 2016, In : New England Journal of Medicine. 375, 7, p. 631-643 13 p.

Research output: Contribution to journalArticle

367 Scopus citations

Association between serum IgE level and adverse clinical endpoints in primary sclerosing cholangitis

Tabibian, J. H., Enders, F., Imam, M. H., Kolar, G., Lindor, K. & Talwalkar, J. A., 2014, In : Annals of Hepatology. 13, 3, p. 384-389 6 p.

Research output: Contribution to journalArticle

Open Access
11 Scopus citations

Association of adiposity, measures of metabolic dysregulation, and elevated alanine aminotransferase in subjects with normal body mass index

Treeprasertsuk, S., Romero-Corral, A., Somers, V. K., Sierra-Johnson, J., Lindor, K. D., Angulo, P. & Lopez-Jimenez, F., Oct 1 2014, In : Asian Biomedicine. 8, 5, p. 585-595 11 p.

Research output: Contribution to journalArticle

Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis

Musso, G., Gambino, R., Tabibian, J. H., Ekstedt, M., Kechagias, S., Hamaguchi, M., Hultcrantz, R., Hagström, H., Yoon, S. K., Charatcharoenwitthaya, P., George, J., Barrera, F., Haflidadóttir, S., Björnsson, E. S., Armstrong, M. J., Hopkins, L. J., Gao, X., Francque, S., Verrijken, A., Yilmaz, Y. & 13 others, Lindor, K. D., Charlton, M., Haring, R., Lerch, M. M., Rettig, R., Völzke, H., Ryu, S., Li, G., Wong, L. L., Machado, M., Cortez-Pinto, H., Yasui, K. & Cassader, M., Jul 2014, In : PLoS Medicine. 11, 7, e1001680.

Research output: Contribution to journalArticle

233 Scopus citations

Autoimmune liver diseases

Abbas, G. & Lindor, K. D., Jan 1 2011, Autoimmune Disorders: Symptoms, Diagnosis and Treatment. Nova Science Publishers, Inc., p. 1-34 34 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

B cell depletion therapy exacerbates murine primary biliary cirrhosis

Dhirapong, A., Lleo, A., Yang, G. X., Tsuneyama, K., Dunn, R., Kehry, M., Packard, T. A., Cambier, J. C., Liu, F. T., Lindor, K., Coppel, R. L., Ansari, A. A. & Gershwin, M. E., Feb 2011, In : Hepatology. 53, 2, p. 527-535 9 p.

Research output: Contribution to journalArticle

56 Scopus citations

Bone disease in patients with primary sclerosing cholangitis

Angulo, P., Grandison, G. A., Fong, D. G., Keach, J. C., Lindor, K. D., Bjornsson, E. & Koch, A., Jan 2011, In : Gastroenterology. 140, 1, p. 180-188 9 p.

Research output: Contribution to journalArticle

64 Scopus citations

Cancer risk, screening and surveillance in primary sclerosing cholangitis

Chascsa, D. M. & Lindor, K. D., Sep 1 2019, In : Minerva gastroenterologica e dietologica. 65, 3, p. 214-228 15 p.

Research output: Contribution to journalArticle

2 Scopus citations

Cancer risk in primary sclerosing cholangitis: Epidemiology, prevention, and surveillance strategies

Fung, B. M., Lindor, K. & Tabibian, J. H., 2019, In : World journal of gastroenterology. 25, 6, p. 659-671 13 p.

Research output: Contribution to journalReview article

13 Scopus citations

Cancer surveillance in patients with primary sclerosing cholangitis

Razumilava, N., Gores, G. J. & Lindor, K. D., Nov 1 2011, In : Hepatology. 54, 5, p. 1842-1852 11 p.

Research output: Contribution to journalReview article

175 Scopus citations

Characteristics and Outcomes Reported by Patients With Primary Sclerosing Cholangitis Through an Online Registry

Kuo, A., Gomel, R., Safer, R., Lindor, K., Everson, G. T. & Bowlus, C. L., Jun 1 2019, In : Clinical Gastroenterology and Hepatology. 17, 7, p. 1372-1378 7 p.

Research output: Contribution to journalArticle

2 Scopus citations

Clinical implications of serial versus isolated biliary fluorescence in situ hybridization (FISH) polysomy in primary sclerosing cholangitis

Quinn, K. P., Tabibian, J. H. & Lindor, K., Dec 1 2016, (Accepted/In press) In : Scandinavian Journal of Gastroenterology. p. 1-5 5 p.

Research output: Contribution to journalArticle

11 Scopus citations

Clinical spectrum and management

Björnsson, E. S. & Lindor, K., Feb 1 2014, Autoimmune (IgG4-Related) Pancreatitis and Cholangitis. Springer New York, p. 171-179 9 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Colon Neoplasms Develop Early in the Course of Inflammatory Bowel Disease and Primary Sclerosing Cholangitis

Thackeray, E. W., Charatcharoenwitthaya, P., Elfaki, D., Sinakos, E. & Lindor, K. D., Jan 1 2011, In : Clinical Gastroenterology and Hepatology. 9, 1, p. 52-56 5 p.

Research output: Contribution to journalArticle

46 Scopus citations

Complications, symptoms, quality of life and pregnancy in cholestatic liver disease

Zakharia, K., Tabibian, A., Lindor, K. & Tabibian, J. H., Mar 2018, In : Liver International. 38, 3, p. 399-411 13 p.

Research output: Contribution to journalReview article

15 Scopus citations

Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

Younossi, Z. M., Loomba, R., Rinella, M. E., Bugianesi, E., Marchesini, G., Neuschwander-Tetri, B. A., Serfaty, L., Negro, F., Caldwell, S. H., Ratziu, V., Corey, K. E., Friedman, S. L., Abdelmalek, M. F., Harrison, S. A., Sanyal, A. J., Lavine, J. E., Mathurin, P., Charlton, M. R., Chalasani, N. P., Anstee, Q. M. & 4 others, Kowdley, K. V., George, J., Goodman, Z. D. & Lindor, K., Jul 2018, In : Hepatology. 68, 1, p. 361-371 11 p.

Research output: Contribution to journalReview article

105 Scopus citations

Current and promising therapy for primary biliary cholangitis

Gossard, A. A. & Lindor, K., Jun 13 2019, In : Expert Opinion on Pharmacotherapy. 20, 9, p. 1161-1167 7 p.

Research output: Contribution to journalReview article

3 Scopus citations

Current management of primary sclerosing cholangitis in pediatric patients

Ibrahim, S. H. & Lindor, K. D., Mar 7 2011, In : Pediatric Drugs. 13, 2, p. 87-95 9 p.

Research output: Contribution to journalReview article

25 Scopus citations

Current therapies for nonalcoholic fatty liver disease

Gossard, A. A. & Lindor, K. D., Dec 1 2011, In : Drugs of Today. 47, 12, p. 915-922 8 p.

Research output: Contribution to journalReview article

20 Scopus citations

Design and Endpoints for Clinical Trials in Primary Sclerosing Cholangitis

Ponsioen, C. Y., Lindor, K., Mehta, R. & Dimick-Santos, L., Sep 1 2018, In : Hepatology. 68, 3, p. 1174-1188 15 p.

Research output: Contribution to journalReview article

17 Scopus citations

Diagnosis and management of primary biliary cirrhosis

Ali, A. H., Carey, E. J. & Lindor, K., Dec 1 2014, In : Expert Review of Clinical Immunology. 10, 12, p. 1667-1678 12 p.

Research output: Contribution to journalReview article

5 Scopus citations

Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis

Younossi, Z. M., Loomba, R., Anstee, Q. M., Rinella, M. E., Bugianesi, E., Marchesini, G., Neuschwander-Tetri, B. A., Serfaty, L., Negro, F., Caldwell, S. H., Ratziu, V., Corey, K. E., Friedman, S. L., Abdelmalek, M. F., Harrison, S. A., Sanyal, A. J., Lavine, J. E., Mathurin, P., Charlton, M. R., Goodman, Z. D. & 4 others, Chalasani, N. P., Kowdley, K. V., George, J. & Lindor, K., Jul 2018, In : Hepatology. 68, 1, p. 349-360 12 p.

Research output: Contribution to journalReview article

113 Scopus citations

Distinguishing immunoglobulin G4–related disease from its pancreatobiliary mimics: Are we there now?

Tabibian, J. H. & Lindor, K., Aug 1 2016, In : Hepatology. 64, 2, p. 340-343 4 p.

Research output: Contribution to journalEditorial

6 Scopus citations

Editorial: Itching to Know: Role of Fibrates in PBC

Levy, C. & Lindor, K., Jan 1 2018, In : The American journal of gastroenterology. 113, 1, p. 56-57 2 p.

Research output: Contribution to journalArticle

Open Access
2 Scopus citations

Editorial: is proton pump inhibitor use associated with worse outcomes in patients with liver abscesses?

Tabibian, J. H. & Lindor, K., Apr 1 2018, In : Alimentary Pharmacology and Therapeutics. 47, 8, p. 1226-1227 2 p.

Research output: Contribution to journalEditorial

1 Scopus citations
8 Scopus citations

Efficacy and safety of curcumin in primary sclerosing cholangitis: an open label pilot study

Eaton, J. E., Nelson, K. M., Gossard, A. A., Carey, E. J., Tabibian, J. H., Lindor, K. D. & LaRusso, N. F., May 4 2019, In : Scandinavian Journal of Gastroenterology. 54, 5, p. 633-639 7 p.

Research output: Contribution to journalArticle

7 Scopus citations

Emerging drugs for the treatment of Primary Biliary Cholangitis

Ali, A. H., Tabibian, J. H., Carey, E. J. & Lindor, K., Jan 2 2016, In : Expert Opinion on Emerging Drugs. 21, 1, p. 39-56 18 p.

Research output: Contribution to journalArticle

12 Scopus citations

Emerging therapeutic targets for primary sclerosing cholangitis

Kalani, A., Tabibian, J. H. & Lindor, K., Jul 3 2018, In : Expert Opinion on Orphan Drugs. 6, 7, p. 393-401 9 p.

Research output: Contribution to journalReview article

Eyewitnesses to history and participants as well

Lindor, K. D., Dec 1 2011, In : Hepatology. 54, 6, 1 p.

Research output: Contribution to journalComment/debate

Factors Associated With Prevalence and Treatment of Primary Biliary Cholangitis in United States Health Systems

FOLD Investigators, Jan 1 2018, (Accepted/In press) In : Clinical Gastroenterology and Hepatology.

Research output: Contribution to journalArticle

12 Scopus citations

Farnesoid X receptor agonists for primary biliary cirrhosis

Lindor, K. D., May 1 2011, In : Current Opinion in Gastroenterology. 27, 3, p. 285-288 4 p.

Research output: Contribution to journalArticle

38 Scopus citations

Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response

the GLOBAL PBC Study Group, Nov 1 2019, In : Alimentary Pharmacology and Therapeutics. 50, 10, p. 1127-1136 10 p.

Research output: Contribution to journalArticle

Open Access
7 Scopus citations

Foreword

Lindor, K., Jan 1 2014, In : Unknown Journal. p. vii-viii

Research output: Contribution to journalArticle

Gender differences in academic productivity and leadership appointments of physicians throughout academic careers

Reed, D. A., Enders, F., Lindor, R., McClees, M. & Lindor, K. D., Jan 2011, In : Academic Medicine. 86, 1, p. 43-47 5 p.

Research output: Contribution to journalArticle

137 Scopus citations

Hepatic fibrosis and the renin-angiotensin system

Abbas, G., Silveira, M. G. & Lindor, K. D., Nov 1 2011, In : American Journal of Therapeutics. 18, 6, p. e202-e208

Research output: Contribution to journalArticle

21 Scopus citations

Hepatocellular carcinoma: Low risk of HCC in patients who have PSC and cirrhosis

Gossard, A. A. & Lindor, K., May 2014, In : Nature Reviews Gastroenterology and Hepatology. 11, 5, p. 276-277 2 p.

Research output: Contribution to journalArticle

6 Scopus citations

High-dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis

Imam, M. H., Sinakos, E., Gossard, A. A., Kowdley, K. V., Luketic, V. A. C., Edwyn Harrison, M., McCashland, T., Befeler, A. S., Harnois, D., Jorgensen, R., Petz, J., Keach, J., Decook, A. C., Enders, F. & Lindor, K. D., Nov 2011, In : Alimentary Pharmacology and Therapeutics. 34, 10, p. 1185-1192 8 p.

Research output: Contribution to journalArticle

61 Scopus citations

High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis

Eaton, J. E., Silveira, M. G., Pardi, D. S., Sinakos, E., Kowdley, K. V., Luketic, V. A. C., Harrison, M. E., McCashland, T., Befeler, A. S., Harnois, D., Jorgensen, R., Petz, J. & Lindor, K. D., Sep 2011, In : American Journal of Gastroenterology. 106, 9, p. 1638-1645 8 p.

Research output: Contribution to journalReview article

164 Scopus citations

Immunoglobulin G4-associated autoimmune cholangiopathy

Lindor, K. D., Apr 1 2011, In : Gastroenterology and Hepatology. 7, 4, p. 259-261 3 p.

Research output: Contribution to journalComment/debate

7 Scopus citations

Increased Waitlist Mortality and Lower Rate for Liver Transplantation in Hispanic Patients With Primary Biliary Cholangitis

Cholankeril, G., Gonzalez, H. C., Satapathy, S. K., Gonzalez, S. A., Hu, M., Khan, M. A., Yoo, E. R., Li, A. A., Kim, D., Nair, S., Wong, R. J., Kwo, P. Y., Harrison, S. A., Younossi, Z. M., Lindor, K. & Ahmed, A., Jun 2018, In : Clinical Gastroenterology and Hepatology. 16, 6, p. 965-973.e2

Research output: Contribution to journalArticle

8 Scopus citations